N/A
Manufactured by Janssen Products, LP
16,304 FDA adverse event reports analyzed
Last updated: 2026-04-14
APALUTAMIDE is a medication tracked in the FDA Adverse Event Reporting System (FAERS), manufactured by Janssen Products, LP. The most commonly reported adverse reactions for APALUTAMIDE include RASH, DEATH, FATIGUE, HOT FLUSH, PRODUCT DOSE OMISSION ISSUE. This page provides a comprehensive breakdown of reported side effects, safety signals, patient demographics, and AI-powered safety analysis for APALUTAMIDE.
Out of 10,955 classified reports for APALUTAMIDE:
The FDA classifies an adverse event as “serious” if it results in death, hospitalization, disability, congenital anomaly, or requires intervention to prevent permanent damage.
Demographics reflect voluntary FDA adverse event reporting patterns and may not represent the full patient population.
This profile reflects 16,304 FDA FAERS reports that mention APALUTAMIDE. Reporting is voluntary and does not prove that the drug caused any listed event.
Frequently reported terms in FAERS include RASH, DEATH, FATIGUE, HOT FLUSH, PRODUCT DOSE OMISSION ISSUE, ASTHENIA. Rankings reflect reporting volume in this dataset, not confirmed side effect rates in the general population.
Labeling and FAERS entries often list Janssen Products, LP in connection with APALUTAMIDE. Always verify the specific product and NDC with your pharmacist.